Three major drug companies spent $100 billion dollars on Research and devleopment in the last five years.
Three major generic drug companies spent under $10 billion on research and development in the last five years.
Since important new drugs are almost impossible to find the major drug companies are likely to find fewer new drugs over the next ten years as their cash flow will decline.
Since generic companies don't do much research or find too many new drugs, the net result will be less drugs, more illness and consequently, more expense.
Unless we get very lucky and the drug companies have a few more breakthroughs.
Furthermore, there is a strong likelihood of declining morale and a significant weakening of the talent who are able to find new drugs.
Three major generic drug companies spent under $10 billion on research and development in the last five years.
Since important new drugs are almost impossible to find the major drug companies are likely to find fewer new drugs over the next ten years as their cash flow will decline.
Since generic companies don't do much research or find too many new drugs, the net result will be less drugs, more illness and consequently, more expense.
Unless we get very lucky and the drug companies have a few more breakthroughs.
Furthermore, there is a strong likelihood of declining morale and a significant weakening of the talent who are able to find new drugs.
